Saturday, July 11, 2026

pharma · Helicobacter Pylori · Type 2 Diabetes

Shandong Jinpharm Co.,Ltd

Shandong Jinpharm Co.,Ltd drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Linyi, CN HQ
5 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Linyi, CN
Employees
5
Programs
3
Drugs
5
Patents
0
Intelligence · Drug Pipeline

Shandong Jinpharm Co.,Ltd pipeline

Portfolio lens on 5 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Shandong Jinpharm Co.,Ltd drug portfolio — 5 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

5 compounds
  1. Development asset linked to Shandong Jinpharm Co.,Ltd in public FDA and regional records.

  2. Development asset linked to Shandong Jinpharm Co.,Ltd in public FDA and regional records.

  3. msc

    Development asset linked to Shandong Jinpharm Co.,Ltd in public FDA and regional records.

  4. Development asset linked to Shandong Jinpharm Co.,Ltd in public FDA and regional records.

  5. Development asset linked to Shandong Jinpharm Co.,Ltd in public FDA and regional records.